DEFA14A: MultiSensor AI Secures $14M Private Placement

Sentiment:

Private Placement Announcement 30 October 2025 8:16 PM

📋All filings for Multisensor Ai Holdings, INC

MultiSensor AI Holdings, Inc. announced a $14 million private placement of common stock and warrants, anchored by 325 Capital, LLC, to fund strategic growth and platform development.

Delay expectedThe full $14.0 million capital raise is subject to stockholder approval for the issuance of shares exceeding 19.99% of the Company's outstanding common stock prior to the Subscription Date.If stockholder approval is not obtained by February 28, 2026, investors will be refunded all amounts paid into the escrow account for the remaining shares and warrants, indicating a potential delay or failure to secure the full intended capital.

Capital raiseMultiSensor AI Holdings, Inc. is conducting a private placement to raise gross proceeds of approximately $14.0 million.The placement includes 34,229,826 shares of common stock and warrants to purchase up to 68,459,652 shares of common stock at $0.409 per share.An initial closing of $2.85 million has occurred, with the remaining $11.15 million contingent on stockholder approval by February 28, 2026.The Company engaged Roth Capital Partners, LLC as the exclusive placement agent, paying a 5.0% cash fee on gross proceeds.

Summary

MultiSensor AI Holdings, Inc. (MSAI) entered into a private placement agreement to raise gross proceeds of approximately $14.0 million.
The placement involves the sale of 34,229,826 shares of common stock and warrants to purchase up to 68,459,652 shares of common stock.
The purchase price per share and warrant exercise price is $0.409.
Roth Capital Partners, LLC is acting as the exclusive placement agent, receiving a 5.0% cash fee of gross proceeds.
An initial closing occurred on October 30, 2025, raising $2.85 million for 6,970,890 shares and warrants for 13,941,780 shares.
The remaining $11.15 million (for 27,258,936 shares and warrants for 54,517,872 shares) is contingent upon stockholder approval of the private placement by February 28, 2026.
Net proceeds are intended for working capital, general corporate purposes, strategic growth initiatives, and advancing the MSAI Connect platform.
Warrants have a seven-year term, full ratchet antidilution protection (minimum exercise price $0.14944), no voting rights, but participate in dividends/distributions.
A Series A Convertible Preferred Stock was created on October 27, 2025, to be issued if warrant exercise would exceed a 49.5% beneficial ownership limitation.
Voting agreements were signed with stockholders representing over 36.5% of outstanding common stock to support the transaction and obtain stockholder approval.

Sentiment

Score: 7

Explanation: The capital raise provides crucial funding for strategic growth and platform development, which is a positive for the company's future. However, the significant dilution and the contingency of the full amount on stockholder approval introduce some uncertainty and risk, balancing the overall sentiment to moderately positive.

Positives

Secured $14.0 million in gross proceeds, providing significant capital for operations and growth.
The capital infusion is earmarked for working capital, strategic growth initiatives, and advancing the MSAI Connect platform.
Anchored by 325 Capital, LLC, a long-term, significant minority owner, indicating strong investor confidence.
Voting agreements from stockholders representing over 36.5% of outstanding common stock increase the likelihood of obtaining the necessary stockholder approval for the full placement.

Negatives

The full $14.0 million capital raise is contingent on obtaining stockholder approval by February 28, 2026, with a refund to investors if not met.
The issuance of 34,229,826 shares of common stock and warrants for 68,459,652 shares will result in significant dilution for existing shareholders.
The Company is restricted from certain subsequent equity sales (Variable Rate Transactions) for 24 months without Finance Committee approval, potentially limiting future financing flexibility.
The Company acknowledges that the issuance of securities may result in substantial dilution of outstanding common stock.

Risks

Failure to obtain stockholder approval by February 28, 2026, would result in a refund of the escrowed funds for the remaining $11.15 million, impacting the total capital raised.
Significant dilution of existing common stock due to the issuance of 34,229,826 shares and warrants for 68,459,652 shares.
Restrictions on future equity sales, particularly Variable Rate Transactions, for 24 months could limit the Company's ability to raise capital quickly under certain market conditions.
The exercise price of warrants is subject to full ratchet antidilution protection, which could further increase the number of shares issued if the stock price drops.

Future Outlook

The Company intends to use the net proceeds from the private placement for working capital and other general corporate purposes, including driving strategic growth initiatives and continuing to advance the development of the MSAI Connect platform. The balance of the offering is expected to close in December 2025, subject to stockholder approval.

Management Comments

The reaffirmed commitment from our investors reinforces our strategic vision and validates the progress we continue to make.
We remain focused on disciplined execution, operational excellence, and delivering sustainable long-term value for our shareholders.

Industry Context

MultiSensor AI operates in the growing market of AI-powered industrial condition-based maintenance and process control solutions. This capital raise provides funding to advance its integrated multi-sensing platforms and edge/cloud software, aligning with broader industry trends towards digital transformation and predictive analytics in industrial settings.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Composition Restriction	The Company agreed not to increase the size of its board of directors to more than seven directors without the prior written consent of 325 Capital until the two-year anniversary of the final closing date of the Private Placement.	October 24, 2025	Grants 325 Capital significant influence over board size, potentially impacting future governance flexibility.
Most Favored Nation Provision	The Purchase Agreement contains a most favored nation provision, allowing investors to claim preferable terms from any future securities offering by the Company.	October 24, 2025	Ensures current investors receive terms no less favorable than future investors, potentially limiting the Company's flexibility in future capital raises.
Voting Agreements	Certain stockholders, representing greater than 36.5% of outstanding common stock, entered into voting agreements to support the Private Placement and obtain Stockholder Approval.	October 30, 2025	Increases the likelihood of obtaining necessary stockholder approval for the full private placement, demonstrating alignment among key shareholders.
Beneficial Ownership Limitation	Warrants are not exercisable if it would cause beneficial ownership to exceed 49.5% of issued and outstanding Common Stock, converting instead to Series A Convertible Preferred Stock.	October 24, 2025	Prevents any single investor from gaining majority control through warrant exercise without further action, protecting other shareholders.

Related Party Transactions

325 Capital, LLC, a lead investor in the private placement, beneficially owns more than 5.0% of the Company's outstanding Common Stock.
Daniel M. Friedberg, a Managing Member of 325 Capital, serves on the Company's board of directors.

Stakeholder Impact

Shareholders: Significant dilution from the issuance of new shares and warrants; potential for increased share value if capital is effectively used for growth; voting power impacted by new issuances and voting agreements.
Investors (Purchasers): Opportunity to acquire common stock and warrants at a set price; potential for future gains if the company grows; most favored nation rights in future financings.
Employees: Potential for enhanced job security and growth opportunities due to increased working capital and strategic initiatives.
Customers: Potential for improved products and services through continued advancement of the MSAI Connect platform.
Creditors: Improved financial stability and liquidity due to the capital raise, potentially reducing credit risk.

Next Steps

File a proxy statement on Schedule 14A with the SEC within fifteen (15) days of the Initial Closing.
Hold a special meeting of stockholders at the earliest practical date thereafter to obtain Stockholder Approval for the Private Placement.
File a registration statement with the SEC to register the resale of the Shares and the shares of Common Stock and Preferred Stock issuable upon exercise of the Warrants.
Close the balance of the offering (approximately $11.15 million) in December 2025, subject to stockholder approval.

Key Dates

Date	Description
October 7, 2025	Date of prior letter agreement between Company and Placement Agent, superseded by current agreement.
October 24, 2025	Date of report, Placement Agency Agreement, Securities Purchase Agreement, and press release announcing pricing of Private Placement.
October 27, 2025	Effective date of Certificate of Designations for Series A Convertible Preferred Stock; expected initial closing date mentioned in press release.
October 30, 2025	Actual initial closing date of the Private Placement; date of Registration Rights Agreement and Voting Agreements.
December 2025	Expected closing date for the balance of the offering, subject to stockholder approval.
February 28, 2026	Deadline for obtaining stockholder approval for the Private Placement; investors will be refunded escrowed amounts if not obtained.
April 7, 2026	End of Placement Agent's exclusive engagement term.
April 7, 2027	End of Right of First Refusal period for Placement Agent for future financings.
October 2032	Approximate expiration date for the warrants (seven years from issuance).

Recommendation

hold

The $14 million private placement, anchored by a significant investor, provides MultiSensor AI with crucial capital for strategic growth and platform development, which is a positive operational development. However, the transaction involves substantial dilution for existing shareholders, and the full funding is contingent on future stockholder approval, introducing a degree of uncertainty. Additionally, restrictions on future financing methods and the most-favored-nation clause could impact long-term financial flexibility. While the capital infusion is beneficial, the dilutive effects and contingent nature of the full raise suggest a 'Hold' recommendation for a seasoned investor, awaiting clearer execution on strategic initiatives and the successful completion of the full financing.

Keywords

MultiSensor AI, MSAI, Private Placement, Capital Raise, Warrants, Common Stock, 325 Capital, Roth Capital Partners, SEC Filing, Dilution, Corporate Governance, Stockholder Approval, AI-powered solutions, Industrial IoT, Condition-based Maintenance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.